What can I do about reflux?

How is reflux treated?

Barthelsson C, Lützen K, Anderberg B, Bringman S, Nordström G. Patients' experiences of laparoscopic fundoplication in day surgery. Ambul Surg 2003; 10 (2): 101-107.

Boghossian TA, Rashid FJ, Thompson W, Welch V, Moayyedi P, Rojas-Fernandez C et al. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database Syst Rev 2017; (3): CD011969.

Federal Institute for Drugs and Medical Devices (BfArM). Proton pump inhibitors (prescription forms): risk of bone fractures and hypomagnesaemia, prompt for text adjustment. 07/26/2012.

Dent J, Jones R, Kahrilas P, Talley NJ. Management of gastro-oesophageal reflux disease in general practice. BMJ 2001; 322 (7282): 344-347.

Dibley LB, Norton C, Jones R. Don't eat tomatoes: patient's self-reported experiences of causes of symptoms in gastro-oesophageal reflux disease. Fam Pract 2010; 27 (4): 410-417.

Eom CS, Park SM, Myung SK, Yun JM, Ahn JS. Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies. Ann Fam Med 2011; 9 (3): 257-267.

Garg SK, Gurusamy KS. Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev 2015; (11): CD003243.

Ip S, Chung M, Moorth D, Yu WW, Lee J, Chan JA et al. Comparative effectiveness of management strategies for gastroesophageal reflux disease: update. (AHRQ Comparative Effectiveness Reviews; Volume 29).

Johnstone J, Nerenberg K, Loeb M. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia. Aliment Pharmacol Ther 2010; 31 (11): 1165-1177.

Jones R, Hunt C, Stevens R, Dalrymple J, Driscoll R, Sleet S et al. Management of common gastrointestinal disorders: quality criteria based on patients' views and practice guidelines. Br J Gen Pract 2009; 59 (563): e199-208.

Kahrilas PJ, Howden CW, Hughes N. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease. Am J Gastroenterol 2011; 106 (8): 1419-1425; quiz 1426.

Koop H, Fuchs KH, Labenz J, Lynen Jansen P, Messmann H, Miehlke S et al. Gastroesophageal reflux disease (S2k guideline). AWMF registration number: 021-013. 05.2014.

Kwok CS, Yeong JK, Loke YK. Meta-analysis: risk of fractures with acid-suppressing medication. Bone 2011; 48 (4): 768-776.

Leiman DA, Riff BP, Morgan S, Metz DC, Falk GW, French B et al. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis. Dis Esophagus 2017; 30 (5): 1-9.

Rickenbacher N, Kotter T, Köchen MM, Scherer M, Blozik E. Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis. Surg Endosc 2014; 28 (1): 143-155.

Sigterman KE, van Pinxteren B, Bonis PA, Lau J, Numans ME. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2013; (5): CD002095.

Song H, Zhu J, Lu D. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions. Cochrane Database Syst Rev 2014; (12): CD010623.

Sun S, Cui Z, Zhou M, Li R, Li H, Zhang S et al. Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis. Neurogastroenterol Motil 2017; 29 (2).

Wang Y, Pan T, Wang Q, Guo Z. Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthrough. Cochrane Database Syst Rev 2009; (4): CD004275.

IQWiG health information is intended to help understand the advantages and disadvantages of important treatment options and health care offers.

Whether one of the options we have described actually makes sense in individual cases can be clarified in a conversation with a doctor. Gesundheitsinformation.de can support the discussion with doctors and other experts, but not replace it. We do not offer individual advice.

Our information is based on the results of high quality studies. They are created by a team of authors from medicine, science and the editorial team and reviewed by experts outside of IQWiG. In our methods, we describe in detail how we develop our texts and keep them up to date.